Discovery points toward a new strategy for treating Parkinson’s disease

By | September 23, 2021
University of Utah Health scientists have identified a molecule that slows cells’ production of alpha-synuclein, a protein that forms toxic aggregates in the brains of people with Parkinson’s disease.